Gene · 4005
Papers2,403
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
1 to 20 of 2,403
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Correction: Degradation of LMO2 in T cell leukaemia results in collateral breakdown of transcription complex partners and causes LMO2-dependent apoptosis. | Elife | 2026 | 42766340 | PubTator, text mining | PubMed |
| The machine-learning classifier ALLCatchR2 identifies 20 T-ALL subtypes across cohorts and age groups. | Hemasphere | 2026 | 42741738 | PubTator, text mining | PubMed |
| High Histological Skeletonization as a Measure of Heterogeneity Is Associated with Poor Overall Survival and Death Within 2 Years of Diffuse Large B-Cell Lymphoma. | Cancers (Basel) | 2026 | 42738349 | PubTator, text mining | PubMed |
| LMO2 regulates STAT3 localization to the nucleus in breast cancer cells. | MicroPubl Biol | 2026 | 42602493 | PubTator, text mining | PubMed |
| Acute erythroid leukaemia transformation in polycythaemia vera with leukemic involvement in liver and ascites. | BMJ Case Rep | 2026 | 42547260 | PubTator, text mining | PubMed |
| High Histological Entropy Is Correlated with Poor Overall Survival and Death Within the First 2 Years in Diffuse Large B-Cell Lymphoma. | Cancers (Basel) | 2026 | 42512344 | PubTator, text mining | PubMed |
| Oncogenesis as an Adverse Effect of Gene Replacement Therapy in Hematopoietic Stem Cells. | Int J Mol Sci | 2026 | 42511445 | PubTator, text mining | PubMed |
| Mtg16/Eto2 tumor suppressor maintains and establishes repression by distinct mechanisms. | Mol Cell | 2026 | 42309063 | PubTator, text mining | PubMed |
| Clinicopathological Characteristics and Prediction of Overall Survival and Death Within 2 Years in Diffuse Large B-Cell Lymphoma Based on Histological Images and Deep Learning. | Biomedicines | 2026 | 42193459 | PubTator, text mining | PubMed |
| Impact of aging on CD146+ mesenchymal stromal cells-mediated regulation of bone marrow CD34+ hematopoietic stem/progenitor cell mobilization. | Front Bioeng Biotechnol | 2026 | 42183054 | PubTator, text mining | PubMed |
| CTCF Regulates Erythroid Differentiation Through Control of Core Erythroid Transcription Factors. | Biomolecules | 2026 | 42072669 | PubTator, text mining | PubMed |
| High-Resolution Genomic Characterization of WAGR Spectrum Disorder: Insights From a Novel Cohort and Literature Synthesis, and Validation of Patient-Reported Data. | Am J Med Genet A | 2026 | 41968606 | PubTator, text mining | PubMed |
| The JMJD family histone demethylases: structure, mechanism of action, diseases and therapeutic targets. | Mol Biomed | 2026 | 41857315 | PubTator, text mining | PubMed |
| Insights from pooled CRISPRi single-cell screens in K562 cells reveal gene functions, regulatory networks, and highlight opportunities and limitations. | BMC Genomics | 2026 | 41826830 | PubTator, text mining | PubMed |
| Single-cell transcriptomics reveals cellular and genetic mechanisms of alpine adaptation in Rosa sericea. | Front Plant Sci | 2026 | 41799984 | PubTator, text mining | PubMed |
| BCL11B enhancer hijacking by t(14;16)(q32;q24) translocation defines a novel high-risk subtype of T-ALL. | Blood | 2026 | 41790573 | PubTator, text mining | PubMed |
| Frequent NPM1 mutation, monoblastic/monocytic origin and prognostic significance of organ and system involvement in myeloid sarcoma: a multicenter study. | J Pathol Clin Res | 2026 | 41781345 | PubTator, text mining | PubMed |
| Daratumumab-based salvage therapy enables umbilical cord blood transplantation in multiline refractory, elderly T-lymphoblastic lymphoma: a case report. | Front Immunol | 2026 | 41766881 | PubTator, text mining | PubMed |
| Repurposed Acarbose Targets Nidogen-1 to Remodel the Tumor Stroma and Suppress Portal Vein Tumor Thrombus in Hepatocellular Carcinoma. | Research (Wash D C) | 2026 | 41756725 | PubTator, text mining | PubMed |
| Burkitt Lymphoma-A Guide to Biological Features, Diagnosis and Differential Diagnosis. | Cancers (Basel) | 2026 | 41749833 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/4005/papers